Literature DB >> 30377100

[Dexmedetomidine alleviates postoperative cognitive dysfunction in aged rats probably via silent information regulator 1 pathway].

Sitong Fang1, Yong Chen1, Peng Yao1, Yiling Li1, Yujun Yang1, Guohai Xu1.   

Abstract

OBJECTIVE: To explore the role of silent information regulator 1 (SIRT1) signaling pathway in mediating the effect of dexmedetomidine (DEX) to alleviate postoperative cognitive dysfunction (POCD) in aged rats.
METHODS: Seventy-two healthy male Sprague-Dawley rats aged 18-20 months (weighing 500-700 g) were randomized equally into normal control group, POCD model group, DEX pretreatment group, and DEX and SIRT1 inhibitor (EX527) pretreatment group. In the latter 2 groups, DEX (25 μg/kg) was injected intraperitoneally in the rats 30 min before the operation, and normal saline was injected instead in the other 2 groups; in EX527 group, EX527 (1 μg/kg) was injected intravenously 5 min before the operation. In all but the control group, the rats were subjected to laparotomy lasting 30 min, and on days 1, 3, and 5 following the operation, 6 rats were randomly selected from each group for Morris water maze test to evaluate their cognitive functions. Immediately after the test, the rats were sacrificed and the hippocampus was collected for determination of the levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) using ELISA; Western blotting was used to detect the expression of SIRT1 and nuclear factor- κB (NF-κB) in the hippocampal neurons.
RESULTS: Compared with the control rats, the rats in POCD group and EX527 group showed significantly prolonged escape latency, decreased frequency of crossing the original platform, increased TNF-α and IL-6 levels, lowered SIRT1 expression in the hippocampal neurons, and increased NF-κB expression (P < 0.05), and these parameters were comparable between POCD group and EX527 group (P > 0.05). DEX pretreatment significantly alleviated cognitive dysfunction and attenuated the changes in TNF-α, IL-6, SIRT1, and NF-κB expressions induced by the operation (P < 0.05), and EX527 pretreatment of the rats obviously blocked the effects of DEX (P < 0.05).
CONCLUSIONS: DEX alleviates POCD in aged rats probably via SIRT1 signaling pathway.

Entities:  

Keywords:  aged; cognition disorders; dexmedetomidine; sirtuin 1

Mesh:

Substances:

Year:  2018        PMID: 30377100      PMCID: PMC6744197          DOI: 10.12122/j.issn.1673-4254.2018.09.08

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  26 in total

1.  Advantageous effects of dexmedetomidine on haemodynamic and recovery responses during extubation for intracranial surgery.

Authors:  G Turan; A Ozgultekin; C Turan; E Dincer; G Yuksel
Journal:  Eur J Anaesthesiol       Date:  2008-04-10       Impact factor: 4.330

Review 2.  Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations.

Authors:  M Mahmoud; K P Mason
Journal:  Br J Anaesth       Date:  2015-08       Impact factor: 9.166

3.  Structure-based design of pseudopeptidic inhibitors for SIRT1 and SIRT2.

Authors:  Tero Huhtiniemi; Heikki S Salo; Tiina Suuronen; Antti Poso; Antero Salminen; Jukka Leppänen; Elina Jarho; Maija Lahtela-Kakkonen
Journal:  J Med Chem       Date:  2011-09-07       Impact factor: 7.446

4.  Preventive effects of dexmedetomidine on the development of cognitive dysfunction following systemic inflammation in aged rats.

Authors:  Daiki Yamanaka; Takashi Kawano; Atsushi Nishigaki; Bun Aoyama; Hiroki Tateiwa; Marie Shigematsu-Locatelli; Fabricio M Locatelli; Masataka Yokoyama
Journal:  J Anesth       Date:  2016-10-13       Impact factor: 2.078

Review 5.  Ubiquitination in signaling to and activation of IKK.

Authors:  Zhijian J Chen
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

Review 6.  Transcription factor NF-kappaB as a potential biomarker for oxidative stress.

Authors:  R van den Berg; G R Haenen; H van den Berg; A Bast
Journal:  Br J Nutr       Date:  2001-08       Impact factor: 3.718

7.  Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease.

Authors:  Jürgen Knobloch; Chiara Wahl; Maria Feldmann; David Jungck; Justus Strauch; Erich Stoelben; Andrea Koch
Journal:  Basic Clin Pharmacol Toxicol       Date:  2013-09-30       Impact factor: 4.080

8.  Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase.

Authors:  Fan Yeung; Jamie E Hoberg; Catherine S Ramsey; Michael D Keller; David R Jones; Roy A Frye; Marty W Mayo
Journal:  EMBO J       Date:  2004-05-20       Impact factor: 11.598

9.  Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts.

Authors:  Xiaoxia Zhu; Qiong Liu; Meimei Wang; Minrui Liang; Xue Yang; Xue Xu; Hejian Zou; Jianhua Qiu
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

10.  Electroacupuncture Alleviates Postoperative Cognitive Dysfunction in Aged Rats by Inhibiting Hippocampal Neuroinflammation Activated via Microglia/TLRs Pathway.

Authors:  Pei-Pei Feng; Pu Deng; Li-Hua Liu; Qi Ai; Jie Yin; Zhe Liu; Gai-Mei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-08       Impact factor: 2.629

View more
  2 in total

1.  Dexmedetomidine Attenuates Neuroinflammation In LPS-Stimulated BV2 Microglia Cells Through Upregulation Of miR-340.

Authors:  Yang Bao; Yijun Zhu; Guangbao He; Hongwei Ni; Chenxia Liu; Limin Ma; Lifeng Zhang; Dongping Shi
Journal:  Drug Des Devel Ther       Date:  2019-10-03       Impact factor: 4.162

2.  Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis.

Authors:  Xiong Zhang; Yongxing Li; Yong Wang; Yuerong Zhuang; Xiaojie Ren; Kai Yang; Wuhua Ma; Ming Zhong
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.976

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.